0.86 (-%)
As of Nov 21, 2024
Source:
Durect Corp is a biopharmaceutical company advancing novel and potentially lifesaving investigational therapies derived from our Epigenetic Regulator Program. Larsucosterol, a new chemical entity in clinical development, is the lead candidate in our Epigenetic Regulator Program.
| Country | United States |
| Headquarters | cupertino, california |
| Phone Number | (408) 777-1417 |
| Industry | manufacturing |
| CEO | James E. Brown, D.V.M |
| Website | www.durect.com |